The Asia-Pacific pharma industry experienced a 38% drop in new job postings in Q3 2023 compared with the previous quarter, with the highest share accounted for by AstraZeneca with 1,720 job postings, according to GlobalData’s analysis of pharma company job postings. GlobalData’s Pharma: Hiring Trends & Signals Q3 2023 report reveals comprehensive insights into hiring patterns, job roles, required skills, geographical trends, and key themes within the pharmaceuticals industry, facilitating anticipation of future workforce needs. Buy the report here.
Notably, Management Occupations jobs accounted for a 21% share of the Asia-Pacific pharma industry’s total new job postings in Q3 2023, drop 53% over the prior quarter.
Management Occupations drive pharma industry hiring activity
Management Occupations, with a share of 21% new job postings, was the occupation with the greatest hiring activity in the Asia-Pacific pharma industry in Q3 2023 , ahead of Healthcare Practitioners and Technical Occupations with a 12% share of new job postings.
The other prominent roles included Computer and Mathematical Occupations with a 9% share in Q3 2023, Business and Financial Operations Occupations with a 6% share and Life, Physical, and Social Science Occupations with a 5% share of new job postings.
Top five companies accounted for 43% of hiring activity
AstraZeneca posted 1,720 jobs in Q3 2023 and registered a decline of 4% over the previous quarter, followed by Pfizer with 1,061 jobs and a 28% drop. Novartis, with 996 jobs, and Biocon, with 915 jobs, recorded a 42% drop and a 76% drop, respectively, while Sanofi recorded a 3% increase with a 822 new job postings during Q3 2023.
Regional analysis of hiring in the Asia-Pacific pharma industry, Q3 2023
India held the leading share of the Asia-Pacific pharma hiring activity with a 38.54% share, a 51% decrease over Q2 2023. China was next with 32.23%, four-percentage-point down over the previous quarter.
For further understanding of GlobalData's Pharma: Hiring Trends & Signals Q3 2023, buy the report here.